Philip A. Sharp, Director at BIOGEN IDEC INC. (BIIB), sold 76,850 shares at $64.41 ($5.0M) on 2008-04-08, disclosed to the SEC on 2008-04-10.
Scheduled sale ($5.0M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $63.71 | 100 | $6K | 0.1% |
| 2 | $63.82 | 205 | $13K | 0.3% |
| 3 | $63.83 | 295 | $19K | 0.4% |
| 4 | $63.86 | 27 | $2K | 0.0% |
| 5 | $63.88 | 100 | $6K | 0.1% |
| 6 | $63.89 | 1,573 |
| $100K |
| 2.0% |
| 7 | $63.93 | 2,000 | $128K | 2.6% |
| 8 | $64.11 | 8 | $513 | 0.0% |
| 9 | $64.12 | 400 | $26K | 0.5% |
| 10 | $64.13 | 600 | $38K | 0.8% |
| 11 | $64.14 | 592 | $38K | 0.8% |
| 12 | $64.16 | 300 | $19K | 0.4% |
| 13 | $64.17 | 500 | $32K | 0.6% |
| 14 | $64.18 | 300 | $19K | 0.4% |
| 15 | $64.19 | 100 | $6K | 0.1% |
| 16 | $64.20 | 100 | $6K | 0.1% |
| 17 | $64.31 | 1,200 | $77K | 1.6% |
| 18 | $64.32 | 1,900 | $122K | 2.5% |
| 19 | $64.36 | 600 | $39K | 0.8% |
| 20 | $64.37 | 100 | $6K | 0.1% |
| 21 | $64.38 | 2,000 | $129K | 2.6% |
| 22 | $64.39 | 1,100 | $71K | 1.4% |
| 23 | $64.40 | 2,200 | $142K | 2.8% |
| 24 | $64.41 | 4,700 | $303K | 6.1% |
| 25 | $64.42 | 1,500 | $97K | 1.9% |
| 26 | $64.43 | 1,250 | $81K | 1.6% |
| 27 | $64.44 | 3,100 | $200K | 4.0% |
| 28 | $65.00 | 50,000 | $3.3M | 65.3% |
| Total | $64.75 avg | 76,850 | $5.0M | 100% |
| Filing → |
| ALNY | SELL | 2018-03-13 | $1.9M | — | Filing → |
| ALNY | SELL | 2017-02-03 | $2.0M | — | Filing → |
| ALNY | SELL | 2017-01-27 | $569K | — | Filing → |